|
1）Moody AR, Murphy RE, Morgan PS, et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation. 2003; 107: 3047-52
|
|
|
|
2）Burtea C, Ballet S, Laurent S, et al. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives. Arterioscler Thromb Vasc Biol. 2012; 32: e36-48
|
|
|
|
|
|
3）Briley-Saebo KC, Nguyen TH, Saeboe AM, et al. In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes. J Am Coll Cardiol. 2012; 59: 616-26
|
|
|
|
|
|
4）Morishige K, Kacher DF, Libby P, et al. High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis. Circula-tion. 2010; 122: 1707-15
|
|
|
|
|
|
5）Trivedi RA, U-King-Im JM, Graves MJ, et al. Noninvasive imaging of carotid plaque inflam-mation. Neurology. 2004; 63: 187-8
|
|
|
|
|
|
6）Patterson AJ, Tang TY, Graves MJ, et al. In vivo carotid plaque MRI using quantitative T2* measurements with ultrasmall superparamagnetic iron oxide particles: a dose-response study to statin therapy. NMR Biomed. 2011; 24: 89-95
|
|
|
|
|
|
7）Hyafil F, Vucic E, Cornily JC, et al. Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metallopro-teinases. Eur Heart J. 2011; 32: 1561-71
|
|
|
|
|
|
8）Nahrendorf M, Jaffer FA, Kelly KA, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation. 2006; 114: 1504-11
|
|
|
|
|
|
9）Kang HW, Torres D, Wald L, et al. Targeted imaging of human endothelial-specific marker in a model of adoptive cell transfer. Lab Invest. 2006; 86: 599-609
|
|
|
|
|
|
10）Zeibig S, Li Z, Wagner S, et al. Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis. Circ Res. 2011; 108: 695-703
|
|
|
|
|
|
11）Briley-Saebo KC, Shaw PX, Mulder WJ, et al. Targeted molecular probes for imaging athero-sclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation. 2008; 117: 3206-15
|
|
|
|
|
|
12）Ronald JA, Chen JW, Chen Y, et al. Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques. Circulation. 2009; 120: 592-9
|
|
|
|
|
|
13）Rodriguez E, Nilges M, Weissleder R, et al. Activatable magnetic resonance imaging agents for myeloperoxidase sensing: mechanism of activation, stability, and toxicity. J Am Chem Soc. 2010; 132: 168-77
|
|
|
|
|
|
14）Johansson LO, Bjornerud A, Ahlstrom HK, et al. A targeted contrast agent for magnetic resonance imaging of thrombus: implications of spatial resolution. J Magn Reson Imaging. 2001; 13: 615-8
|
|
|
|
|
|
15）Jaffer FA, Weissleder R. Seeing within: molecular imaging of the cardiovascular system. Circ Res. 2004; 94: 433-45
|
|
|
|
|
|
16）Spuentrup E, Katoh M, Wiethoff AJ, et al. Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model. Rofo. 2007; 179: 1166-73
|
|
|
|
|
|
17）Winter PM, Morawski AM, Caruthers SD, et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha (v) beta3-integrin-targeted nanoparticles. Circulation. 2003; 108: 2270-4
|
|
|
|
|
|
18）van Tilborg GA, Mulder WJ, Deckers N, et al. Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. Bioconjug Chem. 2006; 17: 741-9
|
|
|
|
|